Report
Erin Lash
EUR 850.00 For Business Accounts Only

Morningstar | Clorox Not Immune to Intense Competitive Pressures, but Long-Term Edge Unwavering; Shares Rich

Despite the high-single-digit downdraft in shares following third-quarter results that included 2% sales growth, 60 basis points of gross margin expansion to 43.4%, and 20 basis points of operating margin improvement to 17%, we don’t intend to alter our $138 fair value estimate or long-term outlook (calling for just shy of 4% sales growth on average annually and operating margin gains of 150 basis points relative to fiscal 2018 to 20% over the next decade) for wide-moat Clorox. Even after accounting for this pullback in shares, we continue to view the stock as slightly overvalued, trading at nearly a 10% premium to our valuation.

From our vantage point, the market’s hang-up with the firm’s performance is anchored in the recent erosion in its wipes and bags categories, following actions to raise prices over the last several months to offset inflationary pressures stemming from higher commodity, transportation, and logistics costs (the combination of which negatively affected gross margins in the quarter to the tune of 240 basis points). Management alluded to the fact that a less severe cold and flu season weighed on Clorox’s wipes segment and the category as a whole (which fell at a mid-single-digit clip versus double-digit category growth a year ago). As it pertains to the firm’s wipes business, the firm suggested the shortfall stemmed from widening price gaps, due to increased promotional spending by its competitors.

In light of pricing actions across the consumer products landscape, we’ve long thought volume compression could emerge. However, we haven’t wavered on our stance that in light of Clorox’s long-standing commitment to bring value-added innovation to market and invest to tout this fare in front of consumers, we think these headwinds should prove transitory long term. We forecast Clorox will spend about $700 million annually (12% of sales) on research and development and marketing to support its brand intangible asset.
Underlying
Clorox Company

Clorox is a manufacturer and marketer of consumer products. The company sells its products through mass retailers, grocery outlets, warehouse clubs, dollar stores, home hardware centers, drug, pet and military stores, third-party and owned e-commerce channels, and distributors. The company has four reportable segments: Cleaning, which consists of laundry, home care and other products; Household, which consists of charcoal, bags, wraps and containers, cat litter, and digestive health products; Lifestyle, which consists of food products, water-filtration systems and filters, natural personal care products, and dietary supplements; and International, which consists of products sold outside the United States.

Provider
Morningstar
Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

Analysts
Erin Lash

Other Reports on these Companies
Other Reports from Morningstar

ResearchPool Subscriptions

Get the most out of your insights

Get in touch